Tuesday 01/16/2018

mybesthealthportal.net : The leading source for health, fitness, weight loss, nutrition and anti aging health and wellness information


Top Health Headlines

Depression strikes older women more ofte…

Depression strikes older women more often than men

Older women are more prone to depression and are more likely to remain depressed than are older men,... Read more

Growth Hormone Safety Being Investigated by FDA

Rate this item
(0 votes)

The move comes on the heels of a French study that found certain children given recombinant human growth hormone products had "a small increased risk of death" compared with the overall population.

Earlier this month, European officials said they would review the drugs following the French findings but that safety was not an immediate concern.

The FDA move affects: Novo Nordisk A/S' Norditropin, Roche's NutropinAQ, Novartis AG generics unit Sandoz's Omnitrope, EMD Serono's Saizen, Teva Pharmaceutical Industries Ltd Tev-Tropin and Pfizer Inc's Genotropin, Eli Lilly & Co's Humatrope.

Known chemically as somatropin, recombinant human growth hormone is an injectable protein that aims to stimulate tissue growth, height and metabolism, according to the FDA.

Recombinant human growth hormone products are used to treat a variety of conditions, including short stature in children and adults, Turner syndrome, and chronic renal insufficiency, the agency said.

FDA said it was reviewing the information on the possible risk from recombinant human growth hormone products and would issue any new recommendations regarding the use of recombinant human growth hormone products once it completed its review.

"At this time, FDA recommends that patients continue their recombinant human growth hormone treatment as prescribed by their healthcare provider."

The French review, known as the Sante Adulte GH Enfant (SAGhE) study, began in 2007 and analyzed about 7,000 children who began taking the hormone drug between 1985 and 1996, according to European officials. It has not yet been published.

The study found a 30 percent increase in death in those patients, FDA said. Ninety-three patients taking the hormone died compared with 70 people in the general population in France.

Last modified on Friday, 02 September 2011 12:54
Login to post comments




Most Viewed Articles

Most Recent Comments

Stock Market

An error occured during parsing XML data. Please try again.

Facebook Fans


Nutrition Tools

nutrition tools
Our nutrition tools include free food management systems, meal calculators and a search tool that provides nutrient and calorie content of 7,146 different foods.

Weight Loss Tools

Our weight loss tools and calculators can give you the edge you need to can help you reach your weight loss goals and maintain your weight . They are free to and easy to use.

Metabolic Tools

Use our free metabolic tools and calculators to determine your ideal body weight, your target heart rate, BMI, BMR and more.

Health Tools

Our health tools and health calculators can help you reach your goals and control your health, nutrition and more. It's easy and free to get started.
External links are provided for reference purposes. The World News II is not responsible for the content of external Internet sites. Template Design © Joomla Templates | GavickPro. All rights reserved.

Use of this web site constitutes acceptance of the MyBestHealthPortal.com Terms of Service and Privacy Policy. The information on this site is for educational use only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Placement of product information or advertisements does not constitute and endorsement of the products of services described. MyBestHealthPortal.com is a registered trademark of the Behar Health Network.

Login or Register

Facebook user?

You can use your Facebook account to sign into our site.

Log in with Facebook



User Registration
or Cancel